6-Fluoro-3-Hydroxypyrazine-2-Carbonitrile CAS 356783-31-8 Purity ≥98.0% (HPLC) Favipiravir Intermediate COVID-19
Umkhiqizi onokuhlanzeka Okuphezulu kanye Nekhwalithi Ezinzile
I-Favipiravir yezohwebo kanye Nezixhumanisi Ezihlobene:
I-Favipiravir CAS 259793-96-9
I-2-Aminopropanediamide CAS 62009-47-6
I-Diethyl Aminomalonate Hydrochloride CAS 13433-00-6
I-3,6-Dichloropyrazine-2-Carbonitrile CAS 356783-16-9
3,6-Difluoropyrazine-2-Carbonitrile CAS 356783-28-3
I-6-Fluoro-3-Hydroxypyrazine-2-Carbonitrile CAS 356783-31-8
I-6-Bromo-3-Hydroxypyrazine-2-Carboxamide CAS 259793-88-9
3-Hydroxypyrazine-2-Carboxamide CAS 55321-99-8
Igama Lekhemikhali | I-6-Fluoro-3-Hydroxypyrazine-2-Carbonitrile |
Omqondofana | 6-Fluoro-3-oxo-3,4-Dihydropyrazine-2-Carbonitrile |
Inombolo ye-CAS | 356783-31-8 |
Inombolo yeCAT | I-RF-API294 |
Isimo Sesitoko | Esitokweni, Isikali Sokukhiqiza Sifika Emakhulwini Amakhilogremu |
I-Molecular Formula | I-C5H2FN3O |
Isisindo samangqamuzana | 139.09 |
Ibhrendi | I-Ruifu Chemical |
Into | Imininingwane |
Ukubukeka | Impushana Ephuzi Okuphaphathekile ukuya kokumhlophe |
Ukuhlonza | IR, HPLC |
Umswakama (KF) | ≤1.0% |
Izinsalela ekushiseni | ≤0.50% |
Ukungcola Okukodwa | ≤1.0% |
Ukungcola Okuphelele | ≤2.0% |
Izinsimbi Ezisindayo | ≤20ppm |
Ubumsulwa | ≥98.0% (nge-HPLC) |
Izinga Lokuhlola | I-Enterprise Standard |
Ukusetshenziswa | I-Intermediate ye-Favipiravir (CAS 259793-96-9);I-Antiviral;I-COVID 19 |
Iphakheji: Ibhodlela, isikhwama se-Aluminium foil, isigubhu seCardboard, 25kg/Drum, noma ngokwezidingo zekhasimende.
Isimo Sesitoreji:Gcina ezitsheni ezivaliwe endaweni epholile neyomile;Vikela ekukhanyeni, umswakama kanye nezinambuzane.
I-6-Fluoro-3-Hydroxypyrazine-2-Carbonitrile (CAS 356783-31-8) iyi-Intermediate ye-Favipiravir (CAS 259793-96-9).I-Favipiravir umuthi omusha we-antiviral obanzi oqondiswe ku-RNA polymerase (RdRp) encike ku-RNA.I-Favipiravir yasungulwa ngasekupheleni kweminyaka yawo-1990 yinkampani eyathengwa kamuva inkampani yaseJapan i-Fujifilm njengengxenye yoshintsho isuka ebhizinisini lezithombe iye ekunakekelweni kwezempilo.Ngemva kokuhlolwa ngokumelene nohlu lwamagciwane, umuthi wagunyazwa e-Japan ngo-2014 ukuze usetshenziswe ezimeni eziphuthumayo ngokumelene nezifo eziwumshayabhuqe noma ukwelapha izinhlobo ezintsha zomkhuhlane.Ngesikhathi kuqubuka i-coronavirus entsha, imiphumela yocwaningo lomtholampilo lweSigaba I somuthi olwanyatheliswa ngoMashi 2020 lwabonisa ukuthi umuthi ungaba nomthelela wokusheshisa ukusulwa kwegciwane ukuze unciphise ukuqhubeka kwenyumoniya entsha ye-coronavirus.I-Favipiravir ingasetshenziswa ekwelapheni iziguli ezine-COVID-19 ezinconywe yi-WHO.Kusulwe yi-Drugs Controller General of India (DCGI) ukuze kusetshenziswe "imikhawulo ephuthumayo" phakathi kweziguli ze-COVID-19.